| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lurasidone | alpha-2a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] | 0.25 | approved,investigational | antagonist |
| lurasidone | alpha-2c adrenergic receptor | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] | 0.38 | approved,investigational | antagonist |
| lurasidone | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] | 0.18 | approved,investigational | antagonist |
| lurasidone | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] | 0.4 | approved,investigational | antagonist |
| lurasidone | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] | 0.15 | approved,investigational | antagonist |
| lurasidone | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] | 0.66 | approved,investigational | antagonist |
| click here to return to the previous page | ||||||||